Select Page
AndroGel Trial Continues This Month

AndroGel Trial Continues This Month

There are around 6,000 cases still pending against AbbVie for their testosterone product, AndroGel. Plaintiffs say AndroGel led to blood clots, heart attack, stroke and sudden death. Two trials have already ended both in jury verdicts against AbbVie totaling $290...
×
What Our Clients Are Saying